0001209191-20-063355.txt : 20201214
0001209191-20-063355.hdr.sgml : 20201214
20201214200028
ACCESSION NUMBER: 0001209191-20-063355
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201211
FILED AS OF DATE: 20201214
DATE AS OF CHANGE: 20201214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bratica Joseph
CENTRAL INDEX KEY: 0001820070
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14895
FILM NUMBER: 201387841
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: STE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc.
CENTRAL INDEX KEY: 0000873303
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930797222
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-274-4000
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Sarepta Therapuetics, Inc.
DATE OF NAME CHANGE: 20120712
FORMER COMPANY:
FORMER CONFORMED NAME: AVI BIOPHARMA INC
DATE OF NAME CHANGE: 19980930
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIVIRALS INC
DATE OF NAME CHANGE: 19970123
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-11
1
0000873303
Sarepta Therapeutics, Inc.
SRPT
0001820070
Bratica Joseph
215 FIRST STREET
SUITE 415
CAMBRIDGE
MA
02142
0
1
0
0
Principal Financial Officer
Common Stock
2020-12-11
4
M
0
1115
71.45
A
9255
D
Common Stock
2020-12-11
4
S
0
1115
165.00
D
8140
D
Stock Option (right to buy)
71.45
2020-12-11
4
M
0
1115
0.00
D
2019-03-05
2028-03-05
Common Stock
1115
12285
D
This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction.
/s/ Joseph Bratica
2020-12-14